＊ The Judges might change without any notation, thank you for your understanding.
Health 2.0 LLC
Health 2.0 LLC
Advisor - Japan (Business Development), Health 2.0 / HIMSS
Matthew Holt, Co-Chairman, spent the 1990s learning from the best to be a health care futurist at Institute for the Future, and a survey researcher at Harris Interactive. In the early 2000s he spent time at a PHR start-up, but since he’s been the Founder of (and now occasional author on) The Health Care Blog, and co-founder of the Health 2.0 Conference–roles for which he was mostly self-taught!
Yumiko Nishimura known also as Mimi Nishimura is a producer/consultant specialized in international business development and a writer located in Silicon Valley, USA. She has been active independently (freelance) since 2004.
Prior to be independent, Mimi worked for Stanford University, as the Associate Director of the Comparative Healthcare Policy Research Project at Asia/Pacific Research Center (1991-2004). She joined the project as the senior researcher at the very beginning of it and from 1998 she became the AD immediately under the director of APARC and was responsible for project planning and management in general. She conducted international comparative study of health system/policy, analysis of big-data of Japan, the United States and Europe. The international conference organized by her with timely theme got highly praised. She also led the creation of new businesses working on system development in collaboration with private enterprises and filed joint patents in and US.
As freelance producer, for example, Mimi worked as the Special Contractor for JETRO San Francisco to recruit the investment of US companies to Japanese market (2013−15). She also led the introduction and implementation of the international conference “Health 2.0” to Japan in 2015 and the 4th annual Health 2.0 Asia - Japan conference will be held in December 2018 in Tokyo.
Besides her main jobs, Mimi has worked hard to bring up the international project "Ronald McDonald House" to provide short-term accommodation facilities near hospitals for sick children and families in Japan from the mid90s. In 1998, with Mr. Den Fujita, the Founder & CEO of Japan McDonald's Corporation, she founded Ronald McDonald Children's Charities Japan foundation and established.x
the first house in Japan in 2001 on the premises of the National Center for Child Care and Medical Research in Setagaya Ward, Tokyo. Since then the foundation opened twelve houses in Japan.
Mimi has been producing Maiko Kobayashi, Japanese contemporary artist who is exhibiting her works in Shanghai (March, 2018), Beijing (November, 2018) and Paris(May, 2019).
Born in Yokosuka-city, Japan. Graduated from Ochanomizu University, the Graduate School of Ochanomizu University (MA). After working as a research fellow of the Japan Society for Promotion Science and as a lecturer at Kanagawa University and Jis’sen Women’s University, she relocated to California in 1990 and since then she lives in Silicon Valley, USA.
Dr. Iwami graduated from the Shinshu University School of Medicine and joined the Department of Cardiovascular Medicine at Tokyo Women's Medical University in 1999.
Yo established Medical Oblige Inc (now MedPeer,Inc.) in December 2004.
He launched MedPeer in August 2007.
MedPeer is a professional online social media for certified physicians to share insight of actual medical scene and now it holds more than 100,000 physicians (one of three physicians in Japan).
He continues to be active on the front lines of clinical site, still holding patient consultations once a week.
After acquiring B.A. in law at Waseda university, Yuuri became M.D. at Okayama university. Her subspecialities are plastic surgery and homecare medicine, mainly takes care of decubitus in elders at home. As well as continuing her clinical practice, she started her career as a director for Health 2.0 Asia - Japan from April, 2017. She is heavily motivated in integrating medical practice and technologies, as she sees real needs for technologies in clinical situation.
Dr. Toshio Miyata is a graduate of the Waseda University Department of Mechanical Engineering. He researched and developed artificial heart in the undergraduate. He dreamed to do clinical trial of artificial heart and decided to transfer to the Osaka University School of Medicine. He worked as a cardiac surgeon at the Osaka University Hospital and got involved in the medical treatment of the artificial heart and regenerative medicine but also encountered the problem of device lag which made him to enter the Ministry of Health, Labour and Welfare. He is widely engaged in healthcare reform in Japan; amendment of the Pharmaceutical Affairs Law; Regenerative Medicine Law; increase of clinical research budget; and regulatory reform of clinical trial. He currently works for "MIH clinic" which serves primary healthcare for the local and also offers dialogue with the residents of the community. He also started self-medication tool based on the smartphone technology to utilize the profession of medical doctor and pharmacists.
Koichi Minami led the development project of i2 Healthcare from scratch, that is an original health and productivity management ICT platform of Mitsubishi Chemical Holdings (MCHC). It enables value creation by integration of health-related various data stored separately. He promotes utilization of the system as a basis of KAITEKI Health and Productivity Management in the main MCHC group companies. He has considerable experience in the healthcare industory over 25years, including as a global lead of clinical development project for new drugs in cardiovascular, renal, and urological therapeutic areas. MSc at Kyoto University, MBA at Globis University
Born in Kanagawa in 1976. After the Graduation of University, joined the Giorgio Armani Japan Co., Ltd. After active as top sales, from 2010 participated in the current corporation. In 2014, published the book "Kaigo-Danshi studies" through collaboration between 20 social welfare corporations and creators. 2016-17, "Re Design Project for the Distance" of conventional nursing (Minowa Home), which is rethinking about the privacy of the room and opening the garden to the community. Co-developed nursing care recording system "CareCollabo" with IT companies. 2019 spring,「Deco-Boco nursery school+ plus」Open. Japan College of Social Work, master’s course completion. Main book is “Human resource acquisition strategy of the elderly care industry” in 2015.
John Bass is Founder and CEO of Hashed Health, a healthcare blockchain innovation firm focused on building decentralized solutions for the healthcare market. John has 25 years of experience instarting and leading healthcare technology companies that use technology to drive collaboration and efficiency across health value chains. Since 2015, John has been the leading voice in the development of the global healthcare market. John is an internationally recognized speaker an author on blocichain applications in healthcare. He was recently named Innovator of the Year for his work building distributed products at Hashed, and Hashed Health was recently selected Top Blockchain Developer by Black Book. Prior to Hashed, John was CEO at InVivoLink (sold to HCA) and his experience also includes healthcare B2B startup empactHealth.com (sold to GHX).
Fumiaki was born in Hamamatsu, Japan. After graduating from Jichi Medical University, he began practicing general medicine in the rural areas of Japan and experienced firsthand the issues facing the medical field because of the aging population.
Fumiaki joined the Department of Cardiovascular Medicine at Stanford University in 2001, and over the next 14 years was closely involved with the R&D, animal studies, and clinical studies of many medical devices startups. He has experienced multiple successful exits of the startups that he was deeply involved with, such as Fox Hollow Technologies, Atheromed, KAI Pharmaceutical, CV Ingenuity, etc.
Mr.Kaneko is currently leading IT division as a global head for Miraca Holdings Inc., a leading company for the area of clinical laboratory testing in Japan.
He joined with Mitsui & Co. in 1997 and managed various large-scale, overseas projects such as Sakhalin oil plant, chemical plant, power plant, dinasor museum, etc. After graduated from Rotterdam School of Management, MBA in 2002, he worked for Novartis for 14 years as a leader to establish new projects and teams for both IT and Digital Marketing area. During the tenure, he also led global IT strategy and enterprise architecture for 3 years in Switzerland.
He studied computer science and has earned a master's degree of administration engneering from Keio University.
Dr. Hiroshi MIZUSHIMA graduated from the Tokyo University, faculty of Pharmaceutical Sciences and got PhD in 1988.
He joined National Cancer Center Research Institute and established early age internet systems including Cancer Center Information Network. He also was member of Disease Genome Center.
He also was visiting Professor at Kobe University, adjunt assistant professor at Hawaii University, visiting scientist at NIH, NLM,NCBI.
He moved to Tokyo medical and Dental University, center for medical informatics in 2006, and became Professor of Medical Omics Informatics Division.
He moved to National Institute of public Health in 2011, and became Director of Center for Public Health Informatics in 2017.
He is president of Japanses Association of IT Healthcare, and Medical Blockchain Association. See http://hiroshi.mizushima.info/ for details.
Dr. Mochizuki graduated from Juntendo University School of Medicine in 2000.
After graduating and completing his residency, he became an orthopedic surgeon.
He improved his skill at Institute of Rheumatology Tokyo Women’s Medical University and was appointed director of the Department of Orthopedic Surgery at Kamagaya General Hospital in 2009 and then assistant director of the hospital in 2015.
He specializes in joint surgery and is involved in a wide variety of medical treatments ranging from the acute phase to recovery phase.
Toshio Moritani was born in Japan in 1950. He received his Ph.D. degree in Sports Medicine from the University of Southern California in 1980. In 1985, following faculty appointments at the Texas A&M University, he joined the Department of Integrated Human Studies at Kyoto University. In 1992, he was appointed as Associate Professor of Applied Physiology at the Graduate School of Human and Environmental Studies at Kyoto University and became Professor since 2000. He has retired from Kyoto University and become Professor Emeritus since 2016.
Join The Dai-ichi Mutual Life Insurance Company (now The Dai-ichi Life Insurance Co., Ltd.) in 1997.Experienced in branch office, government office (trainee), Invest Planning Dept., Corporate planning dept., as well as IT Business Plannning Dept..
(in charge of IT strategy, IT governance, IT investment etc.).
Since April 2018, he leads the innovation as general manager of Marketing Strategy Dept. and Director of InsTech Development Center (Director of Dai-ichi Life Innovation Lab).
After enrolling in Showa University’s Faculty of Medicine in 1969, he founded the Showa University Student Newspaper in his second year of medical school. In his fifth year of medical school, he was involved in efforts to organize a national assembly of medical faculties as a representative of Showa University. After graduating from Showa University’s Faculty of Medicine in 1976, he established Medic Media Co., Ltd., in 1979. His company philosophy is as follows: We strive to share specialized medical knowledge in an easy-to-understand manner with as many people as possible. His dream is to build a world in which people are able to stay in close contact with the world of medicine from the time they are old enough to understand what is going on around themselves and will have acquired as much medical knowledge as a typical medical school student by the time they reach adulthood.
Dr. Okiyama is the founder and CEO of Aillis, Inc., an AI medical equipment startup company. He graduated from the University of Tokyo, Faculty of Medicine in 2010 and completed medical residency in Japanese Red Cross Medical Hospital (Tokyo). After the residency he chose to work in a remote island, the Yaeyama Islands in Okinawa, as a flight doctor engaging in emergency medicine.
After coming back to Tokyo, he joined a medical startup company, Medley Inc., as an executive officer.
Now having founded Aillis in 2017, he and his team are developing medical equipment using machine learning as a core algorithm to detect and diagnose influenza.
Dr. Yoshinori Shirono, M.D. and Ph.D., is the founder of Dr.Ci:Labo, the no.1 medical cosmetics skincare brand in Japan. After graduating from the Keio University School of Medicine, Dr. Shirono went on to specialize in dermatological laser surgery at the Japan Medical Laser Laboratory. He established the Shirono Clinic in 1995, offering state-of-the-art laser treatments, a wide range of anti-aging treatments and dermatological surgery.
While seeking the most effective skincare products for his clinical patients, Dr. Shirono could find nothing to meet his high standards and thus created his own masterful skincare line. Dr.Ci:Labo is the result of expertise, extensive research and continuous innovation. Dr. Shirono still works directly with patients today, which enables him to understand current needs and continually reflect the solutions to such needs in Dr.Ci:Labo products.
Graduated from Gifu Pharmaceutical University in 1976, Akiko Sugiura founded Sugi Pharmacy with her husband in Nishio City, Aichi Prefecture in December 1976. From its foundation, she contributed for the local healthcare economy by specializing as "Family Pharmacy" that can manage home care medicine/nursing. From September 2008, she was appointed as President and Representative Director of Sugi Medical. Associate with many hospitals/clinics and their workers, she supports local health and medical care as a member of the Sugi Pharmacy Group. In September 2011, we established the Sugiura Memorial Foundation public interest foundation, to serve for improving national health and welfare, by association with healthcare workers nationwide.
After graduating from Gihu Pharmaceutical University, department of Pharmaceutical Sciences in 2001, Katsunori joined Sugi Pharmacy in 2006 after studied abroad and through his career in Johnson & Johnson. He now is Representative Director & Senior Vice President in Sugi Holdings from 2007, after experienced store manager, Chief of internal management and Managing Director/General Manager at Sales Headquarters. As he continues his career in the company, he gains his passion in combining real store and ICT as a family pharmacy to realize "Region-conclusive" drug store rather than "Hospital-conclusive" to become customer/patient friendly drug store.
Graduated from Meijo university, department of pharmaceutical sciences in 2002, Shinya joined Sugi Pharmacy in 2004 after studied abroad and worked for Sato Pharmaceutical. Previous to his job now from 2017, he had successive jobs as a store manager, product buyer, manager for homecare medicine sales division and exective manager. He experienced every aspects of workflow in sales division, he now holds a mission to integrate medicine, caregiving and prevention through expert "Family Drug Store", to maintain health and beauty for regional customers
Yukinori Takada graduated from Kyoto University with a B.A. in Economics and joined Sumitomo Life Insurance in 1988. He worked for Personnel Planning Department and Market Planning Department to engage in planning related to sales of individual insurance. Served as General Manager of Marketing Planning Dept. from 2011 and General Manager of Corporate Planning Dept. from 2013, he worked on establishment of the Sumitomo Life Medium-Term Business Plan. While contributing to achievement of the goals set out in the plan, he has been involved in establishing partnership with other life insurers, improving Sumitomo Life’s rating status, as well as supervising studies on FinTech.
Currently he serves as a managing executive officer in charge of Vitality strategies and enhancement of customer experience. He strives to spread and expand Vitality in Japan, while strengthening the tied agent channel and the after sales structure for policyholders.
Dr. Tazawa graduated from the Keio University School of Medicine. When he was a medical student, he founded a healthcare venture company and sold it. After residency program, he joined the Department of Neuropsychiatry, School of Medicine, Keio University. Now he is researching diagnosis of depression utilizing artificial intelligence and IoT. In the medical school, he established Keio Healthcare Venture Prize and became the executive committee chairman.
He founded MIZEN Clinic specialized for preventive medicine for workers in 2016.
Fred Trotter, CTO Fred Trotter is a healthcare data journalist and author. He is a founder of CareSet Systems and The DocGraph Journal, a technical blogger for O’Reilly Radar, and co-author of the first Health IT O’Reilly book Hacking Healthcare. Fred Trotter won the 2016 healthcare data liberator award for his work opening significant healthcare data sets. Fred’s technical commentary and data journalism work have been featured in several online and print journals including Wired, Forbes, U.S. News, NPR, Government Health IT, and Modern Healthcare. As a technology entrepreneur, he is an alumnus of multiple successful technical startups including Rackspace, Exault (purchased by Verisign), and ClearHealth (the top Open Source EHR company).
・Positions and Employment
2006-2008 Medical Residency, Tokyo Metropolitan Hiroo General Hospital, Japan
2008-2013 Medical Doctor, Sleep Center, Kuwamizu Hospital, Japan
2009-2012 JSPS Fellow DC1, Department of Stem Cell Biology, Kumamoto University, Japan
2012-2013 Postdoctoral Fellow, Department of Stem Cell Biology, Kumamoto University, Japan
2013-2015 JSPS Fellow PD, Department of sensory and motor systems Tokyo Metropolitan Institute of Medical Science, Japan
2015-present Medical Doctor, Seiwa Hospital, Neuropsychiatric Research Institute
2015-2016 Chief Researcher, Tokyo Metropolitan Institute of Medical Science
2015-present CEO, Sustainable Medicine. Inc,
2016-present Lecturer, Toho University
2016 Research Grant from Naito Foundation
2016 Research Grant from Takeda Science Foundation
2015 Inoue Research Award for Young Scientists, Inoue Foundation
2012 Best presentation award, The Japanese Society of Sleep Research
2008 Travel award, The Japanese Society for Mathematical Biology
After graduating Kitasato university in 1987, Yoshiyuki Numata joined in a foreign-capital pharmaceutical company, as a Medical Representative. With the advantage of his career,from 1992, he worked as a writer for dairy paper specialized for pharmaceutical region, interviewing the ministry of health, labor and welfare, doctors, pharmaceuticals. From Dec. 2008, he joined in Elsevier Japan Inc. as Chief editor for Monthly Mix, which succeeded to Mix Inc. on July 2017 and now he is CEO of Mix Inc.
Occupational Physician of Doyukai medical corporation since 2014. After graduating from University of Environmental Health, He completed clinical training at Omori Red Cross Hospital in 2007. Between 2007 and 2009, he studied the practice of occupational physicians and was conducting research on preventive medicine at Occupational Health Training Center.
He was an occupational physician of Johnson & Johnson k.k. from 2009 to 2014.
Currently, he is an medical adviser to 30 companies as an Occupational physician.
Nobuhiro Sakata, Ph.D. is a Professor of the Department of ICT Education and Research at the Dokkyo Medical University in Tochigi, Japan. He graduated Kitasato University (Japan) and worked at National Defense Medical College (Japan), Columbia University (U.S.A.), University of Missouri, (U.S.A.), Washington University in St. Louis (U.S.A.) and Shinshu University Hospital (Japan). Dr. Sakata and co-worker received the Prime Minister's Award for excellence of their e-MADO system, at the 6th Contest of Internet Application to Educational Activities in 2006. Dr. Sakata is now conducting research on medical and nursing education with communicative robots as a new educational interface. He is also interested in application of those technologies for medical care and nursing care.
After gaining experiences in both traditional and digital marketing fields through the career in an information-tech startup, a world-famous consumer goods manufacturer, and a consulting firm, I joined the Green House Corporation in 2007, which later established the current WIT, and launched a web-based diet coaching service called Asken.
The Asken’s popularity has skyrocketed with the launch of its iPhone app in 2014. Today, the iPhone and Android apps have over 2.5 million users in total, ranked in the top three paid, healthcare apps for several years in the respective app stores.
Our recent focus is the US market and also the medical field. The US version has been available since 2016 and under continuous development while, in the medical field, our app is now in actual use for some clinical studies, including the one funded by the Japan Agency for Medical Research and Development, as an innovative life-intervention tool.
Dr. Chi came to OHSU in 2016 from Johns Hopkins where he served as Medical Director of the Targeted Muscle Reinnervation Program and Medical Director of the Physician Assistant Surgical Residency Program since 2010. Dr. Chi is also commissioned as a Commander in the US Navy Reserve. He is a faculty member in the OHSU Department of Surgery, Division of Trauma, Critical Care and Acute Care. He has a background in biomedical engineering and his clinical research is focused on improving the lives of individuals with traumatic injuries and is specifically focused on the advancement of motor control for individuals with prosthetics. Dr. Chi’s work holds enormous promise for numerous other applications include advancing the human-computer interface for patients with spinal cord injury using robotics and eye control, as well as eye-tracking devices as a means of improving communication and psychosocial status among ICU patients.
Promoting healthcare innovation at home. S-There Technologies is developing a smart toilet device for monitoring biomedical parameters in the urine. Adrian holds a Master of Science in Research applied to Health Sciences and a Bachelor in Nursing. He is an MIT LinQ alumni and has international experience in countries such as United States, Germany, China, Ireland, Norway, Italy or Spain. Going through clinical practice, human resources and research until now, focusing all efforts in entrepreneurship at S-There Technologies.
Mr.Imai graduated from Science and Engineering Fuculty, Keio Universuty, and entered Fujikura Ltd. in 1988. After engaging in material recearch for 10years, he spent 15years in Electronics Business Division, and worked with new product development, manufacturing in Thailand, and sales engineering in Silicon Valley. From 2014, he engaged in making a long term stratefy of the corporate, and established the 2030 vision of Fujikura which was officially announced in March, 2017. The vision declared Fujikura Group should solve the social problems through open innovation. Since April 2017, he has been collecting information globally, and has been leading collaboration with startup companies as General Manager of Silicon Valley Office.
I have worked for 7 years as a physiotherapist in hospital, and I received Ph.D. from the Graduate School of Medicine, Kyoto University.
After that, I founded BackTech Inc., inducted as CEO.
I wrote 30 research papers and is working on the development and management of evidence-based health care services. Currently, we provide a "Pocket Therapist" application for neck/back pain (chronic pain) aimed at corporate employees to improve work related productivity.
Yohei Ishikawa is a co-founder of Mediplat Inc, that is administrating Online-Industrial-Doctor in Japan.He graduated from Jikei University School of Medicine. He worked as an intern at World Health Organization (WHO) in Geneva where he made reports about Global Influenza. He also completed public health program at National Institute of Public Health. Now he is working as a doctor in Department of Emergency Medicine and Critial Care at St.Luke's International hospital, while administering Online-Industrial-Doctor.
Dr. Ito is an innovation catalyst and promoter. He started his career as an engineer at Ricoh and AMD Japan, and after his MBA, he moved to a management position at US headquarters of Motorola and 3Com managing worldwide business lines. He also started a new in-house venture growing it to a division. He returned to Japan and joined Dream Incubator as a management consultant and a venture capitalist. He managed numerous consulting projects for multinationals and provided hands-on help to portfolio companies. Dr. Ito then became a founding member for a fund of Intellectual Ventures, the world's largest invention capital firm. He now manages a venture business and help entrepreneurs. He is a Business Producer and a Mentor at Keihanna Research Complex.
Dr. Ito holds a BSEE from Columbia University, an MBA from Booth School of Business at the University of Chicago, and a Ph.D. from Keio University.
Julius Jockusch is CTO and lead software engineer at SuperGenius. Over the last five years he has been developing for the VR space. Working with Oculus, Microsoft and other studios Julius had a hand in developing the first transformative wave of consumer games and applications in VR and AR. With a background in visual effects and motion graphics, he has an eye for designing engaging spaces, virtual worlds that lead users though the interactive stories, and chasing down and solving the the big problems that must be solved to realize the full opportunity of the virtual world. Recently Julius has turned his gaze towards the medical applications of VR/AR, striving to building tools that help people heal. Taking full advantage of VR, to safely stimulate the real world, Julius helped to produce a virtualized testing environment for robotic prosthetics.
After studying in Australia after graduating from university, after returning home, in April 2012 he was engaged in nursing care at the Koyukai Kanedian Hills Geriatric Health Facility.
In August 2015 he took office as a director of JCS Co., Ltd., and at the same time he was engaged as a manager of the Regional Medical Promotion Division (Medical Social Worker) at Inoue Hospital, Medical Corporation Taiyukai.
In 2016 he took office as Senior Managing Director of CS Co., Ltd. and founded "Visiting Nursing Station Yui".
October 2017 Created KURASERU Co., Ltd. with Rui Hirayama, making full use of careers familiar with nursing care, hospital and visiting nursing. Appointed CEO.
2002~2006 Korea Advanced Institute of Science and Technology
Bachelor of Science (B.S.), Computer Science
2006~2008 Columbia University - Fu Foundation School of Engineering and Applied Science
Masters of Science, Computer Science
2008~2012 Samsung Electronics
2012~2016 Kyunghee University School of Dentistry
Doctor of Dental Medicine, Dentistry
Co-Founder, Business Development
Joined IBM Japan as a new graduate and engaged in a wide range of IT projects, such as ERP implementation, business transformation, system development and so on. In 2016, participated in launching a friend's blockchain startup, experienced business plan and system design utilizing blockchain. In 2017, joined KPMG Consulting and provided the latest ICT strategy for government agencies and ICO consulting services for general corporations. In 2018, established Arteryex inc
Ben Lo is the Co-Founder of Medzii, a product from Grava Labs Corporation, helping people make better decisions around their health and healthcare options. Ben brings a rich background in computer software engineering combined with decades of experience in architecting and releasing complex enterprise platform. Ben holds a bachelor of science degree in computer science from Washington State University as well as a master of science degree in information system from University of Washington.
Johnny Matheny is a pioneer in upper-extremity prosthetics and the world’s first robotic man. Having lost his arm to cancer in 2008, he has had several groundbreaking surgical procedures, including targeted muscle reinnervation and and osteointergration, which allows control of his Johns Hopkins Modular Prosthetic Limb wirelessly with intuitive thought as a seamless natural extension of his missing arm. Matheny has the single most experience with the world’s most advanced limb systems and continues to be a champion for the advancement of prosthetic research. He has never seen his amputation as a disability, but rather an opportunity to help others with upper-extremity loss.
"I will make people happy with technology."
CEO of A10 Lab Inc.
I am an entrepreneur who evolved from Sony 's Internal entrepreneur.
"Michelle" has the effect of 8 times more habit effect than do alone.
Won google play best of 2016/2017.
Established A10 Lab Inc. in 2017 and became independent from Sony.
Developed "Minchalle" as Senior Manager of Sony New Business Creation Division 2015.
At Sony Computer Entertainment in 2011 I worked on setting up a new service for Playstation Network.
Joined Sony Corporation in 2006. I experienced the work of B2B sales and new business and worked as strategic manager.
Worked as a medical representative at Takeda Pharmaceutical Company Limited. Seeing patients waiting for a long time at hospitals and pharmacies, realized better user experience can be provided through better IT medical infrastrucutres. Founded KAKEHASHI, Inc. in 2016.
KAKEHASHI provides SaaS for pharmacies, which innovates patient experience at pharmacies and reduces paper work of pharmacists.
Lincoln is a serial digital health entrepreneur having started one of the first online health records companies. He has spent a decade in software development having worked in bioinformatics, neuroscience, and high throughout data systems at Cisco. He is the CEO and cofounder of Karuna Labs which builds immersive virtual reality technology to treat chronic pain by retraining the brain.
Shuichi Nishio received his MSc. in computer science from Kyoto University in 1994, D. Eng from Osaka University in 2010 and is currently a Principal Researcher at the Advanced Telecommunications Research Institute International (ATR) in Kyoto, Japan. His current research interest includes elderly care using robots and human ability enhancement with brain-machine interface.
Dennis Grishin is co-founder and Chief Scientific Officer at Nebula Genomics where he is building a distributed genomic data generation, sharing and analysis platform. Dennis is also a computer scientist with a Master's degree from Harvard University and a Boehringer Ingelheim Ph.D. Fellow in Genetics and Genomics at Harvard Medical School. Dennis has been selected for the 2019 Forbes 30 under 30 list.
Dr. Ogawa graduated from the Kumamoto University School of Medicine, and joined the Department of Cardiovascular Medicine, Graduate school of Medical Sciences, Kumamoto University.
In November 2015, He launched AMI Co., Ltd.
He has been selected, in 2017, the Destructive Challenge Section of the Inno-vation Program by the Ministry of Internal Affairs and Communications.
His work was published on "Medicine 4.0 - Medicine in the fourth Industrial Revolution", the best seller published in the field of clinical engineering 2018.
Dr. Patel co-founded MyDoc and is also currently a Managing Director of Saena Partners, a Singapore-based investment company. Previously, he was a Senior Vice President at Chandler Corporation, a multi-billion dollar investment fund based in Singapore. In this role, he founded and led the investment team responsible for investing in healthcare businesses in South and Southeast Asia. Prior to moving to Singapore in 2008, Dr. Patel practiced law at Cravath, Swaine & Moore, LLP in New York. He received an M.D. from the Columbia University College of Physicians and Surgeons and a J.D. from Columbia Law School. Upon graduation, he served as a Clinical Fellow at the Harvard Medical School, and was offered a Fulbright Scholarship to study the differences between the Singaporean and US healthcare systems. Dr. Patel was a featured speaker at the 2011 Milken Global Conference and is a member of the Society of Kauffman Fellows.
Dr.Nakanishi graduated from the Kyoto Prefectural University of Medicine and joined the Department of Cardiac Surgery Medicine in 2001.
After that, he joined the Department of Anesthesiology Medicine at Yokohama City University in 2006.His specialized field is emergency intensive care.
He launched T-ICU Co., Ltd. in October 2016 to solve the medical disparity in place and hospital throughout his work.
T-ICU Co., Ltd. won numerous awards in business competitions. He was selected "Thirty Doctors with future vision" in "Medicine 4.0" written by Dr. Hiroaki Kato.
He is working at hospital to care patients three days in a week even now.
His hobbies are baseball and triathlon.
Kazunori holds MA in Oceanic Architecture and Engineering, Nihon University (1996) and MA in Automotive Design, Coventry University (2006). Since age of 17, he suffers brachial plexus palsy on his right arm. Motivated to substitute for his right arm, he cultivates his skills in design and visualisation during the industry's infancy. His skills and knowledges were widely appreciated in construction, civil engineering or car design industries globally. In 2015, he launched KIDS co., ltd. to accrete design, medical and education. Recently he launched a first "ONGAESHI (repayment) project" and developed a unique VR rehabilitation system which eases and reliefs "phantom limb pain." He is also keen to work closely with young designers. He is a key member of the NPO "Mission ARM Japan" which is an organization to provide peer-support / pro-bono for mainly upper limb disabled group of people.
Hanamura Trading Co.,Ltd. was established in 1993 by Founder and President Isamu Hanamura. Previously, an importer and agent for 10 Italian furniture and building material makers, Hanamura renamed his company HANAMURA Co.,Ltd in 2013 based on a new concept as a LUXURY HOME TECHNOLOGY COMPANY. The company's mission is " The promotion of unparalleled innovative products that combine state-of-the-art technology with high sense interior design for a more comfortable and luxurious lifestyle". The company has four main projects: Mirror Display, Mirror Concierge, Smart Home and Design Glass.
Takanori Kobayashi graduated from Niigata university in 2010.
I established NeuroSpace in 2013 to solve fundamental social problems, hundred of thousand of people have suffered from various kind of sleep disorder.
The big reason why I establish NeuroSpace was my own serious experience of sleep disorder.While I was a university student, I suffered from severe fatigue and often could not concentrate on my classes. This was not resolved. On entering the workplace, my problems worsened. Failing to get sufficient sleep duration and quality, both my mental health and my job performance suffered.NeuroSpace have two products.
Solutions on how to solve sleep problems.Technologies evaluating sleep duration and qualities.
So far we have been giving the program to 50 companies and ten thousand employees.
Our core technologies are 3 things, high accurate sensing device under the mattress ,algorithm that can analyze individual characteristics, and smartphone app that provide solutions for good sleep and high performance during work.
Yuji Inoue graduated from the Kyusyu Insutitude of Design University and joined UCHIDA YOKO Co, Ltd. in 1999. He designed statinaly, swivel chair and meeting chair. He designed IT devices and furniture incorporating IT devices with Keio University and Ritsumeikan University. He is on temporary assignment to POWERPLACE Inc. in 2008 and. He is creating real time CG contents at POWERPLACE Inc.
Prof. Takanori Shibata was born in 1967 and received B.S., M.S. and Ph.D. in Electronic and Mechanical Engineering from Nagoya University in 89, 91 and 92, respectively. He was a research scientist at AIST from 93 to 98. Concurrently, he was a visiting research scientist at the AI Lab., MIT from 95 to 98. At the AIST, Dr. Shibata was a senior research scientist from 98 to 13. Concurrently, he was the Deputy Director for Information and Communication Technology Policy, Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan in 2009 and 2010. Since 2013, he has been a professor at School of Computing, Tokyo Institute of Technology, and a visiting fellow at The AgeLab, MIT. He has received many awards including the “Patient Trophy” as innovation of non-pharmacological therapy for dementia by the AP-HP, France, and the Ryman Prize.
Ravi Soin is the Co-Founder of Medzii, a product from Grava Labs Corporation, helping people make better decisions around their health and healthcare options. Ravi holds over 60 patents and has 20+ years of experience building and launching enterprise and consumer products at leading technology companies and healthcare IT companies. He holds a graduate degree in Computer Science from the University of Southern California, as well as a MBA from the University of Washington.
From 2006 through 2011, I contributed to the dissemination of mobile phones equipped with Graphics Processing Unit(GPU) the first time in the world as a 3D graphics expert in QUALCOMM.
From 2012 through 2016, started an IT venture company at California U.S.A. and engaged in AR system, robotics and consulting of new business development.
Started AI venture in Japan in 2016, focusing on image processing, deep learning, IoT. In research entrusted by JAXA, we succeeded in automatically recognizing disaster situations from aerial movies with high accuracy using deep learning.
Since 2017, as a CTO for Medihome Co., Ltd., we will achieve high acucracy in research on automatic recognition of X-ray images.
Dr. Kazuhiko YAMASHITA is director of Takase Clinic since 2018. He has been engaged in researches at University of Tokyo, Tokyo Healthcare University, Osaka University. His research performance includes the research on the influence of electromagnetic field upon cells, the research on the remote bioinstrumentation for home healthcare, the research on RFID technology for medical safety, and the research on instrumentation of physical function for the prevention of falling of elderly people.
Joined in Pfizer-Taito in 1983 as MR. Assigned as an initial member to establish a new medical device division of Pfizer in Japan. In 1992, he took the role of IT Manager of Pfizer Hospital Products Group. In 1996, he held a role of Senior IT Manager of Pfizer's Pharmaceutical division and supported its Sales and Marketing businesses and processes including SFA, SFE, CRM, eMarketing, Mobile etc. Senior Director, Business Technology in 1999 in Japan and New York HQ after 2002. Pfizer Japan Business Technology Lead since 2012.
Shinichiro Okazaki is Deputy Director of Healthcare Industries Division in Japan's Ministry of Economy, Trade and Industry (METI), where he is working on projects promoting preventive healthcare businesses. He is leading a project tackling aging diseases such as dementia in collaboration with AMED (Japan Agency for Medical Research and Development) and other ministries. Prior to his current role, he had been working on international trade, energy, national economic growth strategy, and biotech industry policy. He holds a Bachelor of Law from Kyoto University in Japan and a Master of Business Administration from University of California San Diego.
After the graduation from Waseda University in 1985, entered into Hitachi Sales Corporation.
In 2007, assigned as a first Corporate Business Creator in Hitachi, Ltd.
In 2009, established Brain Science Business Unit in Hitachi HQ, and was assigned as its Unit Leader.
After that Business Unit was tranferred to Hitachi High-Technologies, found NeU Corporation by the joint venture of Tohoku University and Hitachi High-Technologies.
Established Adwell Inc. in Nov 2016, in order to solve aging and health problems by putting big data of ID-POS to good practical use for health care service. His product "SIRU+" provides unique solution for health care with personalized food recommendation based on user's preference, attributes and behavior.
Dr. Tatsunori Taniguchi graduated from Osaka University School of Medicine. After graduation, he had been engaged in clincal practice and research as a cardiologist. He joined Japan Biodesign program as a member of 1st batch fellow at Osaka University and was certificated in 2016.
Dr. Taniguchi established Remohab Inc. in 2017. Remohab is the first spin-off startup from Japan biodesign that develops remote medical care for patients focusing on rehabilitation using IoT.
He also works as a physician and researcher while engaging in medical device development project as Remohab's CEO. He serves a chairman of U40 heart failure network that is the community of young cardiologists.
Mr.Ishikura graduated from the Tottori University Faculty of Medicine School of Life Science and joined Sumitomo Pharmaceutical Co., Ltd. in 2000.
He took charge of practitioners and university hospitals, etc. as a MR（medical representative） in Wakayama-prefecture and Shimane-prefecture. He was engaged as an area academic coordinator in neurological territory and rare disease territory in Kyushu region from 2013.
He made an effort on planning of promotion about antiparkinsonism medicine as a brand leader in the present branch from 2015. And he's working as a manager in the same group from October of this year.
Harold (Hal) Wolf III, is the President and CEO of the Healthcare Information and Management Systems Society (HIMSS). HIMSS consists of HIMSS North America, HIMSS International, cause-based, global membership societies; HIMSS Analytics, the market research and data services group; HIMSS Media, the diversified media and publishing division; PCHAlliance, the Personal Connected Health Alliance; and Health 2.0 the Digital Health Conference - all focused on better health through information and technology.
With nearly 35 years of experience, Wolf is respected internationally as a healthcare and informatics executive with areas of expertise in mhealth, product development, integrated care models, marketing, distribution, information technology and innovation implementation. He has helped health systems and providers across the world with end-to-end operations, commissioning, data and architectural design.
Mr. Fukui joined the Product Planning Department at Japan Post Corporation in 2010.
He was seconded to the Marketing Division at Lawson Co.,Ltd. from 2013 to 2014.
He launched the Japan Post Accelerate Program in September 2017.
He joined Tokyu Accelerate Program Team of Business Development at TOKYU CORPORATION in October 2018.
David Ewing Duncan is an award-winning science and political journalist in print, television, and radio; and the best-selling author of nine books published in 21 languages. His next book is Talking to Robots: Tales from our Human-Robot Futures (Dutton-Penguin, 2019). David is CEO and Curator of Arc Fusion, a recent columnist for the Daily Beast, and a frequent contributor to Wired, Vanity Fair, MIT Technology Review, The New York Times, Atlantic, and others. He has written for Fortune, National Geographic, Discover, Life, Time, Newsweek, and many others. He is a former commentator for NPR's Morning Edition, and a special correspondent and producer for ABC’s Nightline and 20/20. He is the founding director of the Center of Life Science Policy at UC Berkeley. David’s work has won numerous awards, including Magazine Story of the Year from AAAS, and he serves on a select committee of the National Academies of Sciences on science communications. www.davidewingduncan.com
Peter Lund is the Chief Operating Officer at SuperGenius, a virtual reality and video game developer in Portland Oregon. He also serves as chair of the Oregon Games Organization - the state’s games, VR and AR trade group, and on the boards of the Oregon Media Production association and Oregon Story Board. Since 2015 Peter has been fascinated by the intersection of Virtual Reality and healthcare, operating under the hypothesis that the best virtual clinical tools and therapies will be built by combined teams of AAA game developers and clinical experts. Peter met Dr. Chi in 2017. Since then SuperGenius has worked with Dr. Chi and the Applied Physics Laboratory at Johns Hopkins to improve and develop VR training environments for the Modular Prosthetic Limb. Peter and the SuperGenius team believe VR’s true potential to improve lives and patient outcomes is vast and largely unknown. They plan to explore and map that territory in the coming years.
Dr. Mylea Charvat, a clinical psychologist and translational neuroscientist founded Savonix to address a critical challenge in the health care world – how do we assess the cognitive function of patients on a large scale despite limited dollars and insufficient numbers of specialists.
Mylea completed her fellowship in clinical neuroscience at Stanford School of Medicine and has authored peer-reviewed articles published in well-respected journals. Mylea is committed to advancing the integration of cognitive data into mainstream healthcare and chronic disease management. The inspiration for Savonix came when Mylea’s husband was severely injured and she experienced first-hand the difficulty in attaining the vital health data her husband needed to achieve recovery – including cognitive screening.
She realized that if access was difficult for her, it must be impossible for others with no training, expertise or network. When she reached out to the relatives of other patients, she learned that the challenges were widespread and intractable. Mylea made the decision to leave a decade of work and a prestigious career trajectory toward professorship to found Savonix. She committed herself, instead, to addressing the pervasive challenges in access to neurocognitive assessments and the dire need of millions of people for regular, accessible and affordable tests.
Founded Total Brain Care Co., Ltd. in 2015, to realize the solution of social tasks that involve long-term business in the health field and start dementia with "visualization of the cognitive mechanism". Cabinet Office IMPACT Yamakawa PJ's BHQ selection, 500 KOBE 2017 election, Digital Health Connect SOMPO award recipient, Japan Dementia Association regular member, Japan Aromatherapy Society Councilor, RIKEN Secretary of Health Embrittlement Prediction Protection Consortium, Kobe Health University managing director.
Steve Knode is the Deputy Senior Commercial Officer at the U.S. Embassy in Tokyo, Japan. Most recently, he served as the Senior Commercial Officer for U.S. Commercial Service (USCS) in Pakistan, based in Karachi, and previously, the head of USCS in São Paulo, Brazil. Part of the U.S. Department of Commerce (USDOC), USCS is the principal trade and investment promotion agency of the U.S. government. Steve has held a variety of postings with USCS, including as a commercial officer at the Long Island Export Assistance Center, the U.S. Embassy in Budapest, Hungary, and Tokyo, Japan.
Steve also worked at the U.S. Embassy in Kuala Lumpur, Malaysia for the U.S.-Asia Environmental Partnership. Prior to joining the USDOC, Steve spent more than seven years in the public/investor relations industry.
Steve received a B.A. in political science from Denison University, and an MBA from Cornell University’s S.C. Johnson School of Management.
Dr. Yoshitake Yokokura graduated from the Kurume University School of Medicine in March, 1969, and worked for the surgery department of the University. After that he worked for the surgery department of the Detmold Hospital in West Germany for two years (1977-79) He has been President of the Yokokura Hospital since 1990.
He took office as President of the Fukuoka Prefecture Medical Association in 2006. He was elected as President of the Japan Medical Association in April 2012. He also served Council Member of the World Medical Association (WMA) from 2010 to 2016. He serves as President of the WMA (2017-18) and President of the Confederation of Medical Associations in Asia and Oceania (2017-18).
Chigahara spent over two decades in the high-tech industry. He has developed business and led the growth of startup companies. He attained the current role in May 2017. He took roles of CEO and business development director at Freecom Technologies K.K.. He has developed the brand as well as products with “innovative” and “stylish” design for Japanese market and established the nation-wide sales channel. He was also CEO and business development director at FON Wireless Ltd. and led partnership with SoftBank Corp.
Born in Oita prefecture in 1986. CCO (Chief Communication Officer), Publicity. Obtained the bachelor from the University of Tsukuba. He is also the President and the Chief Executive Editor of ZINE Inc.
After graduating from The University of Tokyo College of Arts and Sciences, Shun started working for DeNA. Through his experience as a producer of a social game that generated one billion yen in monthly sales, he transferred to a new project department where he assisted in launching akippa, a parking space reservation service, and launched Robot Taxi, a self-driving taxi and bus service. He left the company in June 2016 to establish BASE FOOD. With “make health a norm by bring innovation to staple foods” as the vision, he developed the world’s first nutritional staple food “BASE PASTA.” Since its release, “BASE PASTA” placed first in Amazon Japan’s food ranking. Currently, the team of six employees are working on domestic popularization and overseas expansion.
I graduated from the University of Tokyo economic department in 2007 and joined Janssen Pharmaceutical K.K.. I was in charge of some hospitals in Tokyo for about two and a half years as MR, transferred to the marketing department in 2010. As marketer, I was in charge of "VELCADE" (multiple myeloma medicine) for about 2 years.
After that, I changed my career to medical society. Launched academic conference management operation, public relations work, PR project for young doctors, medication therapy training project, operation related to new board certified system and so on. After HR venture, joined MICIN from March 2017. Started HR, marketing and sales department, then became the manager of telemedicine unit in January 2018.
Miyako is a Senior Associate at 500 Startups Japan. She sources seed stage startups across a wide range of industries, with a particular focus in healthcare. Prior venture capital, Miyako founded HealthTech News, a media outlet covering how pioneering technologies are impacting the healthcare industry. The site was acquired by M Stage in 2016. She graduated from Keio University, where she studied nursing and medical policy.
After graduating from Tokyo University, Graduate School of Pharmaceutical Sciences, she started her career at the Ministry of Economy, Trade and Industry (METI) in 2006. At METI, she has mainly been in charge of industrial workforce, industrial revitalization, energy conservation, renewable energy and international trade policy, healthcare industry policy before taking on her current role as Director of Medical and Assistive Device Industries Office.
Kellogg School of Management MBA.
April 2016~, Healthcare Indutries Division, Ministry of Economy, Trade and Industry.
Dr. Takakuma is engaging in the projects of clinical trials for the promotion of behaviour modification by using IoT. Also, He is performing the planning of the eco-system of startup acceleration and the creation of innovation on healthcare.
April 2015~, Strategic Planning Office, Mitsubishi-Tanabe Pharma.
April 2004~, Disvorery Research Labratory, Research Division, Mitsubishi-Tanabe Pharma.
He graduated from Graduate School of Pharmaceutical Science, University of Shizuoka and obtained Ph.D. in 2013.
Adam Pellegrini is the General Manager of Fitbit Health Solutions and is tasked with helping Fitbit connect its products, information, data and insights in new and innovative ways into employers, health plans and hospital systems. Pellegrini brings more than 20 years of experience across multiple sectors of the healthcare industry including providers, insurers, health technology and non-profits. Previous to WBA, Pellegrini worked on products like Microsoft HealthVault, HealthyCircles and lead online strategy for the American Cancer Society.
Founder and CEO of Allm Inc. He graduated from Waseda University, Faculty of Science and Technology, and founded SkillUp Japan Corp in 2001 which provides video streaming systems. He spun off the video streaming division to SkillUp Video Technologies Corp. and sold, started to enter the medical ICT industry newly. Due to the company focus shift, he renamed the corporate name to Allm Inc. which originated from "For All Medical" and "For All Mankind" in 2015. Allm Inc. launched a communication app among medical professionals, called "Join" which is the first mobile application as a medical device that covers public insurance system in Japan. He is now expanding the medical ICT business globally and "Join" has been used in U.S, South America, and Europe.
"Ootake is co-founder of YumePro in OKI. Before he launched YumePro,he had been in sales department and delivered semiconductor products, ICT consulting services for central government. Ootake goes by the name of "SAKAMOTO RYOMA of OKI" using an analogy from famous historical innovator, because he has built a lot of new business partnership with companies.
OKI launched YumePro this spring, the word "Yume ", means "dream " in Japanese, which means that OKI will contribute to unlock solutions for our customer’s challenges. and YumePro forcuses on "Healthcare","Smart Logistics" and "Living and life".
Dr. Akihisa Harada is the President & Representative Director of Pfizer Japan Inc. (December, 2017~)
He joined Pfizer as Director for Clinical Research in 1999. He became the acting Head of Regulatory from 2004 and the Head of Clinical Research from 2005. In 2008 he was appointed to Vice President of Development Japan. In addition to his role as the head of Development Japan, he was also a Chief Scientist in Pfizer Japan, responsible for leading Pfizer’s interactions within Japan’s scientific community and associated stakeholders. And then appointed Inflammation & Immunology Japan Lead from 2016-2017.
Dr. Harada graduated from School of Medicine, Kanazawa University and obtained M.D. in 1986. He was trained in Internal Medicine and obtained Doctor of Medical Science from graduate school in Kanazawa University in 1990. He had pursued his career in research field in Immunology and appointed as Visiting Scientist as Windeyer Institute, University College London, UK in 1997 before joining Pfizer.
Kenji Kobayashi began his career working in a management consulting firm, and quickly rose to the position of manager. In 2009 he joined DeNA Co., Ltd. as the Executive Director of HR, and he transformed the HR institutions to form a foundation capable of supporting DeNA’s rapid growth. Afterwards he led DeNA’s mobile game business through a period of dramatic growth, bringing the revenue scale of this business from its initial level of a few billion yen per year to 100 billion yen per year in just two years. After transitioning the game department to a new leader, Kenji oversaw the corporate department, including corporate planning and IR. Then, Kenji graduated from DeNA in 2017 and founded Signifiant Inc. (with a silent "g" and "t") with Yusuke ASAKURA and Taka MURAKAMI to make Japanese startup ecosystem more fertile and robust.
Kenji graduated from the University of Tokyo with a Master’s degree in Aesthetics and Philosophy of Art, where he focused his studies on the topic of performance in western music. In addition to his research, he also founded an orchestra while at the university and played in it as a flutist.
Georgia Mitsi, MBA, PhD, is Senior Director, Head of Digital Health Care Initiatives at Sunovion, where she oversees initiatives that focus on integrating digital health technologies into Sunovion’s solutions to contribute towards the goals to significantly to empower patients to better manage their symptoms and improve quality of life for those who are living with chronic medical conditions. She also contributes to Sunovion’s support of public-private partnerships designed to accelerate digital health care solutions. Dr. Mitsi was recently named as a 2018 PharmaVOICE 100 inspirational leader and digital expert and recognized by CenterWatch as a Top 20 innovator. Dr. Mitsi is a hands-on digital innovator with expertise in health outcomes and health economics research and experience in pharmaceutical and health care industry consulting. She is an active blogger on a variety of digital health care topics, and has authored numerous scientific publications and two novels. Dr. Mitsi has been a long-time supporter and mentor to digital health start-up companies. She holds an MBA in international business from the University of Miami School of Business Administration, and a PhD in Pharmacoepidemiology and MSc in Applied Medical Sciences from the University of Patras.
Tak has invested in over 50 startups related to commerce, health care, SaaS, video, and IoT in the U.S.. To promote awareness about technology and startup culture in Asia, Tak collaborates with media companies and events, such as, TechCrunch Japan, and B Dash Camp. Tak has international experience in the IT industry both as an entrepreneur and as a senior executive. He was the CEO of mixi America. Tak holds a Master’s degree in Nano Science from Waseda University.
Tatsuo Tsutsumi eatablished Gree Ventures, Inc, 7 years ago, and he raised venture fund about 120M USD. Prior to eatablish GREE Ventures, he worked at Recruit Co., Ltd., where he directed new business development, overseeing the establishment and operation of a social media marketing subsidiary and developing business development strategies in areas such as e-commerce, digital content and ad technology. he set up Recruit’s Silicon Valley-based venture capital firm Recruit Strategic Partners, Inc., spearheading efforts to form partnerships with U.S. firms, while also managing Recruit's USD $20 million incubator, Recruit Incubation Partners Co., Ltd. Previously in his career, he oversaw the establishment of CyberAgent’s Venture Capital arm, CA Capital, Ltd. (now CyberAgent Ventures, Inc.) raising a total of USD $50 million through the two funds he managed for that business, which he led to profitability.
Tak Umezawa has advised leading corporations in Japan and the US for over 20 years. Areas of his expertise include strategy, innovation, marketing and organization.
He supports the Japanese government on policy agendas including design and innovation, intellectual property strategy, creative industry development, and taxation, as member of respective government committees.
He leads the "NEXTOKYO Project," a future city vision project for TOKYO. The NEXTOKYO team is composed of 12 leading experts in architecture, urban planning, design, art, sports, media, business and law.
He appears as commentator on "World Business Satellite," a business news program on TV TOKYO. Publications include “Scenario Planning” (Toyo Keizai) and “NEXTOKYO” (co-authored with Shujiro Kusumoto, Nikkei BP). He holds a Bachelor’s degree in Law from the University of Tokyo, and an MBA from MIT Sloan School of Management.
Hiroyuki Watanabe started as a reporter for Nikkei McGraw-Hill, now Nikkei BP, in 1985, and has since become editor and editor-in-chief for vertical publications focusing on Management and IT. His move to the business side was in 2005 when he became responsible for Internet business development. Hiroyuki joined Nikkei, Inc. in 2009 and was one of the key personnel responsible for developing the Nikkei, Online Edition. Since the launch, he is responsible for business operation of the Online Edition and business development for other new digital products and services.
Mr. Kato is the founder and the team manager of Tokyu Accelerate Program(TAP) in Tokyu Corporation. TAP aims to promote the global innovation hub in Shibuya uniquely by collaborating with startups rather than well-established companies, to integrate new ideas provided by startups into the Tokyu group. The program effectively utilizes its advantage of their wide-range business coverage including B to C.
The program, led by the young team leader and the first to use(be set up by) a railway company, supports startups and has been widely acknowledged among Japanese business society as a success case. TAP also seeks to enhance the Quality of Life in Shibuya and cities along the Tokyu railway line by providing services in a unique manner and to convert Japanese industrial structure by developing the Ecosystem. This is broadly in line with the government plan ‘Growth Strategy’. Mr. Kato holds a B.A. in sociology from Hosei University and an MBA from Aoyama Gakuin University.
Education：B.A. in Law, Kyoto University, 1986
1986.4: Joined Nippon Life Insurance Company,2006.3: General Manager Kashiwa Joso Branch,2008.3: General Manager, Metropolitan Area Development Office,2010.3: General Manager, Compliance Dept,2014.3: General Manager, Customer Service Headquarters,2015.3: Executive Officer & General Manager(Marketing Planning Dept & CRM Planning Dept),2016.3: Executive Officer & General Manager(CRM Planning Dept),2016.7: Director(CRM Planning Dept, Product Planning Dept & Marketing Planning Dept) & General Manager(CRM Planning Dept),2017.3: Director
After graduation of Kyoto University, she spent an exciting period in Takeda as a researcher engaging in broad field of frontier science such as genomics, target hunting, MoA analysis, reverse pharmacology. She also served as neuroscientist and led several pre-clinical projects for stroke, depression and schizophrenia. She got PhD from Kyushu University and spent one year in INSERM in France. She is enjoying her current role in Janssen Pharmaceutical Company R&D since April 2014 being in charge of cross-therapeutic area portfolio strategy, new modalities such as regenerative medicine and digital solution, and external collaboration.
Takaaki Hirotsu was born 1972 in Yamaguchi Prefecture. In March 2000, while he was pursuing a doctoral degree at the University of Tokyo, his paper on the olfactory sensitivity of nematodes was published in the British scientific journal Nature. He continued research into nematodes’ sense of smell while serving as a postdoctoral research fellow at Kyoto University Graduate School of Biostudies , and then lecturing at the Kyushu University Faculty of Science. In 2016, he founded HIROTSU BIO SCIENCE INC. to bring to market N-NOSE, a technology employing nematodes’ olfaction for the early detection of cancer. In addition to research and development, today Hirotsu engages actively in educational activities, such as through partnership with a player in the entertainment industry, to create maximum synergy and promote N-NOSE widely as a primary screening tool for cancer.
Yasuto Hoyamatsu/Joined Avex Inc.in 1998
He has been engaged in management of a variety of artists such as TRF and AAA for twenty years in Avex.
Based on his experiences, he has founded a general incorporated association for the sake of the fund of Child's cancer. Moreover, He has established Limited Liability Company "AVEX & HIROTSU BIO EMPOWER LLC." on account of contributing to society through entertainment. He has been inaugurated as a company representative.
Gaining 15 years of experience as a freezer technician and as the 3rd generation of a 70 year old family freezer company, Kinoshita, in July of 2013, sacrificed his position in the family business to revolutionize the food industry through the establishment of Daybreak, a business specialized in Flash Freezing technology. Now, having consulted with over 3,000 companies worldwide, Kinoshita obtained the expertise in Flash Freezing technology to start a new business in food loss. His passion for freezing is second to none.
I am gastrointestinal (GI) specialist physician with Ph.D degree. My speciality is to see patients with Inflammatory Bowel Disease (IBD) and conducting research for overcoming IBD that is one of the most frequently diagnosed GI refractory disease in the world. My 9-year experiences as a GI physician and research interests have let me to choose a position as postdoctoral research fellow at the University of Michigan for 3 years. During my postdoc career, I was also the representative of the Japanese society at the University of Michigan, and met many friends outside the medical field such as engineering and business school. Discussion with my those friends gave me a new perspective to overcome IBD and allowed me to build a team as GCare Inc. Using IT technology, we are developing a new medical system to support with the timely and gentle care that meets the needs of IBD patients.
From a young age, Kota has always sought to use engineering to improve healthcare. As an undergraduate at Kyoto University, Kota developed software for medical device companies and won healthcare business contests. While he was a masters student at the University of Tokyo's engineering department, Kota began developing what would later become Dr.Ubie's core disease prediction model. After working at M3 inc. for 3 years as a software engineer, Kota co-founded Ubie inc. with highschool friend Yoshinori. Combining his engineering prowess with Yoshinori's clinical experience, Kota founded Ubie to make healthcare a better place for everyone.